Arjun Desai
Directeur/Membre du Conseil chez TRISALUS LIFE SCIENCES, INC.
Fortune : 2 M $ au 30/04/2024
Provenance du réseau au premier degré de Arjun Desai
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
18
| Public Company | Pharmaceuticals: Major | 18 |
| Public Company | Medical Specialties | 14 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Arjun Desai via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
United States Surgical Corp.
 United States Surgical Corp. Medical SpecialtiesHealth Technology United States Surgical Corp. engages in the manufacture of wound closure products and surgical devices. It produces tools used in surgery including staplers, sutures, laparoscopic instruments, cardiovascular surgical products and electrosurgical devices. The company was founded in 1964 and is headquartered in North Haven, CT. | Medical Specialties | Corporate Officer/Principal | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| INTUITIVE SURGICAL, INC. | Medical Specialties | Sales & Marketing | |
Healthgrades Operating Co., Inc.
 Healthgrades Operating Co., Inc. Internet Software/ServicesTechnology Services Healthgrades Operating Co., Inc. engages in the provision of health information across digital platforms. It helps to compare providers, review hospital quality, make appointments with clinical providers, prepare for their healthcare appointments, and research comprehensive health and wellness information. The company was founded by Kerry R. Hicks and David G. Hicks in 1998 and is headquartered in Denver, CO. | Internet Software/Services | Founder Director/Board Member | |
General Resonance LLC
 General Resonance LLC Medical SpecialtiesHealth Technology General Resonance LLC provides resonance technology for healthcare and energy products. It focuses on products such as materials, energy and data storage. The firm also provides research and development, commercialization of patent discoveries related to resonance science and its potential applications. The company was founded by Juliana Brooks Mortenson and Reed N. Wilcox on April 9, 2004 and is headquartered in Havre de Grace, MD. | Medical Specialties | Founder General Counsel | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
HistoSonics, Inc.
 HistoSonics, Inc. Medical SpecialtiesHealth Technology HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Director/Board Member | |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Chief Executive Officer Founder | |
| Stanford University | College/University | Corporate Officer/Principal | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Masters Business Admin | |
| University of Utah | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Brigham Young University | College/University | Undergraduate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Undergraduate Degree Graduate Degree | |
| The Pennsylvania State University | College/University | Graduate Degree Undergraduate Degree | |
| St. Joseph's University | College/University | Undergraduate Degree | |
| Utah State University | College/University | Undergraduate Degree Undergraduate Degree | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
American College of Cardiology Foundation
 American College of Cardiology Foundation Medical/Nursing ServicesHealth Services American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC. | Medical/Nursing Services | Chief Executive Officer Chairman | |
| Southern Virginia University | College/University | President President | |
Banyan Biomarkers, Inc.
 Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Manhattan Institute For Policy Research, Inc.
 Manhattan Institute For Policy Research, Inc. Miscellaneous Commercial ServicesCommercial Services Manhattan Institute For Policy Research, Inc. develops and disseminate new ideas for greater economic choice and individual responsibility. It focuses on economic growth, education, energy and environment, health care, legal reform, public sector, race and urban policy. The company was founded by Antony Fisher and William J. Casey in 1977 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
Focused Ultrasound Foundation
 Focused Ultrasound Foundation Miscellaneous Commercial ServicesCommercial Services Focused Ultrasound Foundation is an early-sage company, which engages in the provision of non-invasive therapeutic technology. It focuses on cardiovascular, endocrine disorders, gastrointestinal, musculoskeletal, neurological, oncological, urological, and women''s health sectors. The company was founded by Neal F. Kassell and is headquartered in Charlottesville, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director/Board Member | |
TriSalus Operating Life Sciences, Inc.
 TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
| Reagan-udall Foundation | Director/Board Member | ||
| COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ONCOCYTE CORPORATION | Biotechnology | Director/Board Member | |
| National Comprehensive Cancer Network Foundation | Director/Board Member | ||
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
| Samaritan Health Initiatives, Inc. | President | ||
KMG Capital Partners LLC
 KMG Capital Partners LLC Investment ManagersFinance KMG Capital Partners LLC (KMG Capital Partners) is a venture capital/private equity firm founded in 2012. The firm is headquartered in Denver, Colorado. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
Brandon Point Industries Ltd.
 Brandon Point Industries Ltd. Medical/Nursing ServicesHealth Services Brandon Point Industries Ltd. operates as a life sciences company. It focuses on healthcare. The company was founded in 2014 by George Kelly Martin and John Oliver Thomas Given and is headquartered in Dublin, Ireland. | Medical/Nursing Services | Founder Director/Board Member | |
Empirican Group, Inc.
 Empirican Group, Inc. Packaged SoftwareTechnology Services Empirican Group, Inc. operates a practice-based clinical research site network. It offers Circuit Clinical that streamlines the process while removing cost for physicians in order to bring new medical solutions to patients. The company was founded by Irfan Khan in 2014 and is headquartered in Buffalo, NY. | Packaged Software | Director/Board Member Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Clene Nanomedicine, Inc.
 Clene Nanomedicine, Inc. Pharmaceuticals: MajorHealth Technology Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT. | Pharmaceuticals: Major | Director of Finance/CFO Founder Chairman Chairman Director/Board Member Founder Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
Malin Life Sciences Holdings Ltd.
 Malin Life Sciences Holdings Ltd. Financial ConglomeratesFinance Part of Malin Corp. Plc, Malin Life Sciences Holdings Ltd. functions as an investment holding Irish company. The company is based in Dublin, Ireland. The CEO of the company is George Kelly Martin. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Kensington Capital Holdings LLC
 Kensington Capital Holdings LLC Investment ManagersFinance Kensington Capital Holdings LLC (Kensington Capital) is a private equity firm founded in 2008 by Alison H.Mosca. The firm is headquartered in Foxboro, Massachusetts. | Investment Managers | Private Equity Investor Chief Executive Officer | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 45 |
| Irlande | 5 |
| Suisse | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 11 |
| Technology Services | 4 |
| Health Services | 4 |
| Commercial Services | 4 |
Opérationnelle
| Director/Board Member | 141 |
| Chief Executive Officer | 51 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 43 |
| Chairman | 28 |
Relations les plus connectées
| Insiders | |
|---|---|
| David Matlin | 33 |
| Andrew von Eschenbach | 32 |
| Mats Wahlström | 22 |
| Sean Murphy | 22 |
| George Martin | 20 |
| Mary Szela | 19 |
| Anil Singhal | 15 |
| Reed Wilcox | 13 |
| John Stevens | 13 |
| Mark Mortenson | 13 |
| Kerry Hicks | 12 |
| Morgan Brown | 12 |
| James Alecxih | 12 |
| Jonathon Gay | 9 |
| Shalom Jacobovitz | 8 |
- Bourse
- Insiders
- Arjun Desai
- Connexions Sociétés